News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meyers James R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/05/2023 |
4
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 05/26/2023 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4/A
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/01/2020 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 05/20/2020 |
4
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $10.46, valued at
$156.9k
|
|
| 11/26/2019 |
4
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 30,000 options to buy
@ $9.81, valued at
$294.3k
|
|
| 11/26/2019 |
3
| Meyers James R (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 08/20/2019 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/21/2019 |
4
| Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $11.31, valued at
$158.3k
|
|
| 12/27/2018 |
4
| Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $14.04, valued at
$393.1k
|
|
| 12/27/2018 |
3
| Meyers James R (Director) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 10/22/2018 |
4
| Meyers James R (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 44,000 options to buy
@ $4.71, valued at
$207.2k
|
|
| 10/22/2018 |
3
| Meyers James R (Director) has filed a Form 3 on Arbutus Biopharma Corp |
| 02/23/2018 |
4
| Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 221 shares
@ $62.3475, valued at
$13.8k
Granted 4,846 shares
@ $0
Granted 1,581 shares
@ $0
Paid exercise price by delivering 1,647 shares
@ $80.69, valued at
$132.9k
Gifted 2,323 shares
@ $0
Gifted 2,323 shares
@ $0 |
|
| 02/05/2018 |
4
| Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 75,490 options to buy
@ $83.49, valued at
$6.3M
|
|
| 01/18/2018 |
4
| Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Sold 75,157 shares
@ $79.9961, valued at
$6M
Sold 24,843 shares
@ $80.9925, valued at
$2M
Exercised 100,000 options to buy
@ $21.575, valued at
$2.2M
|
|
| 11/13/2017 |
4
| Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 2,700 shares
@ $0
Paid exercise price by delivering 1,373 shares
@ $73.02, valued at
$100.3k
Gifted 1,327 shares
@ $0
Gifted 1,327 shares
@ $0 |
|
| 11/07/2017 |
4
| Meyers James R (EVP Worldwide Commercial Ops) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 2,212 shares
@ $73.46, valued at
$162.5k
Gifted 2,288 shares
@ $0
Gifted 2,288 shares
@ $0
Exercised 4,500 restricted stock units
@ $0 |
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|